Jitender Jain MD in Roseville, Michigan

Home Michigan Roseville

Jitender Jain MD has Hematology/oncology as his primary medical specialty. Their primary office is: 25959 Kelly Rd A in Roseville, Michigan. They attended Sorry, his university is not listed and graduated in 1971 (around 54 years of experience). They are listed as doing telehealth appointments.

Jitender K Jain MD Office Phone and Directions

Jitender Jain MD
25959 Kelly Rd A
Roseville, Michigan 48066
586-774-9010

Patient Ratings
Please rate your experience with Jitender Jain MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 586-774-9010

Enter a starting address:

Healthcare Info for Jitender Jain MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1971
The Primary Medical Specialty for Jitender Jain MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 54
PAC (PECOS ID)#: 0042209769
NPI #: 1598784100
NPI Created On: 07/18/2006
NPI Last Updated Listed as: 01/30/2012
Primary Taxonomy Code: 207RH0003X
License Number:
JJ033038
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Molina Healthcare of Michigan, Inc.
Humana
Total Health Care USA, Inc.
McLaren Health Plan Community
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Hindi.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Vaccine for influenza for administration into muscle, 0.5 ml dosage
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of drug or substance into a vein for therapy, diagnosis, or prevention
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Prolonged inpatient or observation hospital service first hour
Smoking and tobacco use intensive counseling, greater than 10 minutes
Complex chronic care management services 60 minutes clinical staff time
Chronic care management services at least 20 minutes per calendar month
Advance care planning by the physician or other qualified health care professional
Administration of influenza virus vaccine
Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788455599

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788455603

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783686289

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01

Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783686291

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783468805

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783468815

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783468861

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 819992531

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: NINLARO

Open Associated Drug #1: 63020-078-02

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 819992537

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ICLUSIG

Open Associated Drug #1: 63020-535-30

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843405003

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: LIBTAYO

Open Associated Drug #1: 61755-008-01

Hematology/oncology Professionals in Roseville

1.
Samir Alsawah

25250 Kelly Rd
Roseville, MI
Beaumont Medical Group- Specialty Services

2.
Laura Gowans MD

25250 Kelly Rd
Roseville, MI
Beaumont Medical Group- Specialty Services

3.
Youssef Hanna

25250 Kelly Rd
Roseville, MI
Beaumont Medical Group- Specialty Services

4.
Marianne Huben

25250 Kelly Rd
Roseville, MI
Beaumont Medical Group- Specialty Services

5.
Ishmael Jaiyesimi

25250 Kelly Rd
Roseville, MI
Beaumont Medical Group- Specialty Services

6.
Vera Maranci

18223 E 10 Mile Rd
Roseville, MI
American Oncology Partners Pa

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry